Role of Exogenous Phosphocreatine in Chemotherapy-induced Cardiomyopathy.
We report on a 52-year-old woman with cardiomyopathy following chemotherapy and radiation therapy. The patient did not respond well to b-blockers and angiotensin-converting enzyme inhibitors. After the addition of exogenous phosphocreatine, the patient's cardiac condition improved significantly.
PMID: 29038417 [PubMed - in process]
Source: Reviews in Cardiovascular Medicine - Category: Cardiology Tags: Rev Cardiovasc Med Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cardiology | Cardiomyopathy | Cardiovascular | Chemotherapy | Congestive Heart Failure | Heart | Heart Failure | Myocarditis | Pericarditis | Radiation Therapy